Pharmaceutical marketing that leads with credibility.
Your science holds up. Your pipeline runs on the founder's relationships and reputation, and it stalls the day either runs short. D3 Digital Media installs the operating system that makes your credibility visible to the partners, investors, prescribers, and buyers who decide your future, without a single claim going out unreviewed.
Book a Strategy Call See how WAVES worksIn pharma, the market buys credibility before it buys anything else.
A founder-led or specialty pharma company almost always has the hard part solved: a differentiated asset, real data, a team that knows the science cold. What it usually does not have is a repeatable way to make that credibility visible to people who have never sat across the table from the founder. Partnering conversations, investor diligence, KOL relationships, and formulary access all start with the same question: who are you, and can I trust the science?
Today that question gets answered by the founder, in person, one relationship at a time. It is the most expensive marketing channel you own, it does not scale, and it goes dark the moment the founder is heads-down on a trial, a raise, or an FDA interaction. Meanwhile the buyers you never met are searching, reading, and increasingly asking an AI assistant to summarize you, and finding a thin website and a quiet founder.
Most founder-led pharma companies do not have a marketing problem. They have a visibility problem wearing a marketing problem's clothes.
Two kinds of help, both wrong for pharma.
Agencies that do not know the science
They produce volume, chase impressions, and write copy that a regulatory reviewer will not clear and a scientific buyer will not respect. You spend the engagement teaching them your field, then rewriting everything they hand back. The output is fast and forgettable.
Consultants who only advise
They understand the market and hand you a strategy deck. Then the actual work, the site, the content, the search presence, the cadence, lands back on a team that is already fully committed to the program. Nothing gets built, and the deck ages in a drive.
Pharma needs a third option: a system that respects the regulatory bar, leads with evidence rather than hype, keeps final approval on every claim with your team, and actually gets built and run. That is what WAVES is.
The WAVES operating system, tuned for a regulated market.
WAVES is five capabilities that compound into one loop. Each is adapted to how pharma actually gets evaluated, and you choose how much you run yourself with Coaching, or have our team run for you with WAVES Managed.
Web Presence
The site and search footprint a partner or investor hits during diligence, built to answer their real questions and structured so AI tools summarize your science accurately instead of guessing.
Authority
Search optimization, evidence-led content, and third-party visibility (podcasts, guest platforms) that put your credibility in the room before the first meeting, not after.
Voice
A captured voice profile for the founder and each spokesperson, so everything sounds like your team and stays inside the claims you can actually support.
Engagement
A daily rhythm that surfaces the partners, investors, and buyers signalling intent, so scarce outreach time lands on the few relationships that move the program.
Systems
A shared calendar, a CRM, a weekly scoreboard, and an approval workflow with your compliance sign-off built into the step before anything publishes.
One conversation becomes a month of credible visibility.
The engine is built so the founder's scarcest resource, time and judgment, produces the most output for the least effort. Here is the loop.
We capture the thinking
A recorded interview with the founder or a designated expert. This is the only real time ask, usually a few hours a month, and it is the raw material for everything downstream.
We turn it into assets
Each conversation becomes a long-form article written for search and AI answers, short clips, posts, and, where it fits, a full episode. Evidence-led, never overstated.
Your team approves
Nothing publishes without your compliance sign-off. The approval step is built into the workflow, not bolted on after a problem.
It compounds
Published work keeps ranking and keeps getting found. The weekly scoreboard shows what is landing, and the quarterly checkup resets the plan.
An owned system, not a retainer you rent.
- A search-ready web presence that answers what partners and investors actually look for.
- A captured voice profile for the founder and spokespeople, so the science sounds like your team.
- A steady stream of evidence-led content, published to your site and structured so AI tools cite you correctly.
- An approval workflow with your compliance sign-off in the loop before anything goes live.
- A CRM and a weekly scoreboard, so visibility and pipeline are measured, not assumed.
- A quarterly checkup that resets priorities against what actually moved.
Founder-led and specialty pharma, revenue or pre-revenue.
The fit is a company where one leader still owns the decision and is willing to be in the strategic conversation, where the science is real, and where visibility with partners, investors, or buyers is the constraint on the next stage. Companies with revenue usually run this as Coaching. Clinical-stage and funded pre-revenue companies usually run it as WAVES Managed, because they need the visibility before they have the internal team to build it.
If you are still searching for your asset or your market, that is a different job, and we will say so on the call rather than sell you a system you are not ready to run.
The honest answers.
How do you keep marketing inside our regulatory and compliance bar?
Your team keeps final approval on every claim and asset, and that approval step is built into the workflow before anything publishes. We lead with evidence and a documented voice, so the message stays inside what you can support. Compliance stays with you, by design.
Do you actually understand the science, or will we be teaching you?
We are led by an operator and advised by people who have built enterprise systems for life science and pharma organizations, and through the Life Science Success interviews we have sat with hundreds of leaders in the field. We do not need you to teach us the field to build the system, and the founder's own voice carries the science.
We are clinical-stage and pre-revenue. Is marketing worth it yet?
Often yes, on WAVES Managed. Clinical-stage and funded pharma frequently need visibility with investors and partners before there is revenue, and that is exactly what Managed is built for: making your science and your team visible to the people who fund and partner with you.
How is this different from hiring a pharma PR or med-comms firm?
PR and med-comms chase placements and produce assets on a project basis. WAVES installs an owned, compounding system, your site, search presence, voice, and a repeatable rhythm, that you keep. Visibility does not stop when the retainer ends.
How much of the founder's time does this take?
On WAVES Managed, usually a few hours a month on camera for interviews, plus someone on your team to approve content each week. We handle production, publishing, and the systems. On Coaching, you build it with weekly guidance.
What does it cost?
Coaching starts with a 997 dollar Onboarding Sprint billed with your first month, then 697 dollars a month. WAVES Managed is scoped to your company, typically from 7,500 dollars a month, and starts with a 90-day pilot. We scope it on a strategy call.
See what visibility would do for your pipeline.
A working conversation, no pitch deck, no upsell. We will map where your credibility is leaking and what the operating layer would change, specific to your program.
Book a Strategy Call Life sciences marketing →